LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC was delisted on the 15th of November, 2022.
39 hedge funds and large institutions have $513K invested in LogicBio Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 11 closing their positions.
17% less funds holding
Funds holding: 47 → 39 (-8)
44% less capital invested
Capital invested by funds: $917K → $513K (-$405K)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$45.9K |
| 3 |
VF
Virtu Financial
New York
|
+$32K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$13.7K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$237 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$124K |
| 2 |
Franklin Resources
San Mateo,
California
|
-$109K |
| 3 |
HCA
Harbor Capital Advisors
Chicago,
Illinois
|
-$85K |
| 4 |
Renaissance Technologies
New York
|
-$54.2K |
| 5 |
Jane Street
New York
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| $69 | – | – | – |
|
|
27
Franklin Resources
San Mateo,
California
| – | -$109K | -300,000 | Closed |
|
|
HCA
28
Harbor Capital Advisors
Chicago,
Illinois
| – | -$85K | -235,292 | Closed |
|
|
29
Jane Street
New York
| – | -$18K | -51,381 | Closed |
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$8K | -23,272 | Closed |
|
31
Goldman Sachs
New York
| – | -$4K | -12,298 | Closed |
|
32
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$3K | -11,199 | Closed |
|
33
Citigroup
New York
| – | -$1K | -1,888 | Closed |
|
|
LWANC
34
Laurel Wealth Advisors (North Carolina)
Charlotte,
North Carolina
| – | -$1K | -1,700 | Closed |
|
35
Wells Fargo
San Francisco,
California
| – | +$2 | +5 | +0.4% |
|
36
JP Morgan Chase
New York
| – | +$9 | +24 | New |
|
|
37
Simplex Trading
Chicago,
Illinois
| – | +$237 | +600 | +1,500% |
|
LOGC Hedge Fund Activity: Q3 2022 in Review
39 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q3 2022, worth a combined $513K — down 44% from $917K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of LOGC and 3 opened new positions — a net loss of 8 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $73.7K. The largest seller was Baker Bros. Advisors, cutting an estimated $124K.
- 39 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q3 2022, down from 47 in Q2 2022.
- Funds reported $513K of LogicBio Therapeutics, Inc. Common Stock stock for Q3 2022, down 44% quarter-over-quarter.
- 3 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q3 2022 and 11 closed out, a net change of -8 holders.
- The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $73.7K added.
- The largest LogicBio Therapeutics, Inc. Common Stock seller in Q3 2022 was Baker Bros. Advisors, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2022.